Data for Nonalcoholic steatohepatitis (NASH) changes with S.Q. Leptin administrations (Study ST000677)

(Analysis AN001040)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4F5F6
CerP 34:1; [M-H]-@5.96 0.9913 1.4175 0.8214 1.0336 1.0288 0.7449
CL 66:1; [M-2H](2-)@6.29 0.8763 2.3076 0.6796 1.0602 0.9381 0.4283
CL 70:5; [M-2H](2-)@6.00 0.8145 1.5120 0.9885 1.1081 0.7474 0.9140
CL 74:3; [M-2H](2-)@7.01 0.7910 1.6489 1.2819 1.0359 0.7809 0.7933
FFA(16:0) 1.0627 1.2602 0.9711 0.9743 0.8621 0.9600
FFA(18:0) 1.0265 1.2437 1.0009 0.9929 0.8697 0.9484
FFA(18:1) 1.2471 1.1523 0.9288 0.9072 0.8859 0.9471
FFA(18:2) 1.1959 1.1177 0.8937 0.9003 0.8609 1.1029
FFA(20:0) 0.9251 1.1125 1.0570 1.0549 0.8464 1.0123
FFA(20:1) 1.3833 0.9959 0.8394 0.8943 0.8711 0.9743
FFA(20:2) 1.3092 1.0237 0.8879 0.8989 0.9049 0.9775
FFA(20:4) Arachidonic acid 1.2692 1.0444 0.7771 0.9314 0.7726 1.1476
FFA(22:0) 0.7450 0.6735 1.2612 1.0904 1.0242 1.1483
FFA(22:2) 1.2309 0.8411 0.9355 1.0154 0.8742 0.9308
FFA(22:3) 1.0606 0.8756 0.9235 1.0075 1.0117 1.0239
FFA(24:0) 0.8560 0.9037 1.0783 1.1175 0.7978 1.1320
FFA(24:1) 0.8752 0.6251 1.0577 1.0940 1.0738 1.0848
FFA(24:2) 1.0642 1.0010 0.8104 1.0578 0.8013 1.1040
FFA(24:3) 1.3145 0.8595 0.8280 1.0373 0.6442 1.0577
lysoPE 16:0; [M-H]-@1.69 0.9858 1.0526 0.9904 1.0269 0.7904 1.1371
lysoPE 18:0; [M-H]-@2.49 1.0368 1.0102 0.9094 1.0058 0.8144 1.1766
lysoPE 18:1; [M-H]-@1.86 0.8350 0.9242 1.1802 0.9642 0.8686 1.3654
lysoPE 18:2; [M-H]-@1.40 0.7744 0.9778 1.0441 1.0305 0.9842 1.2308
lysoPE 20:3; [M-H]-@1.68 0.7593 0.7559 0.9468 0.9912 1.4636 1.0763
lysoPE 20:4; [M-H]-@1.37 1.0663 0.7598 0.8644 1.0079 0.8944 1.2492
lysoPE 20:5; [M-H]-@1.13 0.6424 0.3780 0.8805 1.0836 1.1200 1.6561
lysoPE 22:4; [M-H]-@1.99 1.2588 1.1614 0.6466 0.7786 0.9966 1.3030
lysoPE 22:5; [M-H]-@1.58 1.0907 0.8085 1.0124 0.8472 0.9783 1.3766
lysoPE 22:6; [M-H]-@1.34 0.8121 0.5802 0.9672 0.9801 1.0692 1.5296
N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.52 1.0841 0.9058 1.1323 1.0542 0.8141 0.9217
N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.89 0.7901 0.6858 1.1784 1.0831 1.0785 1.0980
N-(tetracosanoyl)-sphing-4-enine; [M-H]-@8.96 0.9737 0.7442 1.1293 1.0599 0.9998 0.9797
PA 34:2; [M-H]-@6.38 0.9092 0.6999 1.4450 0.9221 1.1241 1.0822
PC 28:0; [M-Ac-H]-@5.41 0.9327 1.4247 1.2875 0.9925 0.8256 0.8068
PC 30:0; [M-Ac-H]-@6.11 1.0131 1.2371 0.9332 1.0995 0.7803 0.8565
PC 30:1; [M-Ac-H]-@5.55 0.9847 1.2458 0.9167 1.0679 0.9915 0.7622
PC 32:0; [M-Ac-H]-@6.77 1.0248 1.0086 0.8895 1.0654 0.8325 1.0497
PC 32:1; [M-Ac-H]-@6.25 0.9253 1.4932 0.6935 1.0064 1.0531 0.9071
PC 32:2; [M-Ac-H]-@5.74 0.9250 0.9025 1.4692 1.0461 0.9361 0.8086
PC 33:1; [M-Ac-H]-@6.59 0.9216 1.2314 0.8451 1.0045 1.0432 0.9998
PC 33:2; [M-Ac-H]-@6.11 0.9332 1.0757 1.1194 1.0548 0.7753 1.0559
PC 34:3; [M-Ac-H]-@5.93 1.0036 0.9991 1.0212 1.0674 0.8643 0.9601
PC 34:4; [M-Ac-H]-@5.62 0.8855 0.5148 1.5091 1.0898 1.0451 0.8820
PC 35:2; [M-Ac-H]-@6.70 1.0569 0.8234 1.1390 1.0429 0.9246 0.9245
PC 35:3; [M-Ac-H]-@6.26 0.7223 1.3847 0.9106 1.1145 0.7590 1.1474
PC 36:1; [M-Ac-H]-@7.50 0.9392 1.0732 0.8839 1.0468 0.9340 1.0666
PC 36:3; [M-Ac-H]-@6.54 1.0110 1.0985 1.0337 1.0371 0.8381 0.9725
PC 36:5; [M-Ac-H]-@5.84 0.8881 0.6652 0.8037 1.1297 0.9131 1.2876
PC 37:2; [M-Ac-H]-@7.38 0.9674 1.3548 1.0463 0.8691 1.0500 1.0316
PC 37:3; [M-Ac-H]-@6.86 0.9135 0.9281 0.7930 1.2851 0.9090 0.7270
PC 37:4; [M-Ac-H]-@6.68 1.0363 1.1681 0.8271 1.0829 0.9445 0.8168
PC 37:6; [M-Ac-H]-@5.92 0.7472 0.4983 1.4993 1.0583 1.1044 1.0981
PC 38:2; [M-Ac-H]-@7.64 1.1449 1.4439 0.7973 0.9722 0.8638 0.8471
PC 38:3; [M-Ac-H]-@7.26 1.0337 1.1320 0.8672 1.0321 0.9153 0.9656
PC 38:4; [M-Ac-H]-@6.89 1.2744 0.7455 0.7649 1.0739 0.7217 1.0664
PC 38:5; [M-Ac-H]-@6.52 1.0901 0.7328 0.8870 1.0614 0.8450 1.1451
PC 38:7; [M-Ac-H]-@5.65 0.8601 0.6090 1.0737 1.0500 1.1956 1.0858
PC 40:2; [M-Ac-H]-@8.28 0.7727 0.7388 1.0008 1.1914 1.3903 0.6398
PC 40:4; [M-Ac-H]-@7.45 1.2565 0.8503 0.7217 1.0147 0.8733 1.0356
PC 40:5; [M-Ac-H]-@7.22 0.8837 0.6216 1.1092 1.0003 1.2572 1.0765
PC 40:6; [M-Ac-H]-@6.81 0.9763 0.7141 0.9503 1.0619 0.9388 1.1722
PC 40:7; [M-Ac-H]-@6.36 1.0448 0.6856 0.9236 1.0862 1.0145 0.9852
PC 42:10; [M-Ac-H]-@5.85 1.1033 1.0799 0.5710 0.9922 0.9887 1.1244
PE 32:0; [M-H]-@6.81 0.9708 0.6344 0.6114 1.1296 1.6495 0.5897
PE 32:1; [M-H]-@6.31 0.8775 1.9570 0.7041 1.0568 1.0564 0.5336
PE 34:1; [M-H]-@6.94 0.8597 1.3014 0.9463 1.1184 0.8964 0.8493
PE 34:2; [M-H]-@6.48 0.6962 0.9381 1.3463 1.1670 1.0922 0.7337
PE 34:3; [M-H]-@6.05 0.8435 1.2739 0.8789 1.1522 0.8381 0.9137
PE 35:2; [M-H]-@6.76 0.8846 1.1691 1.1770 1.0976 1.0030 0.6923
PE 36:0; [M-H]-@7.95 1.1551 0.8587 0.8179 0.9036 1.3125 0.9213
PE 36:1; [M-H]-@7.53 0.8101 1.0939 1.2735 1.0659 0.8291 1.0255
PE 36:2; [M-H]-@7.07 0.7874 1.2829 1.1596 1.1165 0.8796 0.8371
PE 36:3; [M-H]-@6.62 0.8124 1.2854 1.1137 1.1079 0.8490 0.8833
PE 36:4; [M-H]-@6.28 1.0477 1.1355 0.9164 1.0826 0.8527 0.8564
PE 36:5; [M-H]-@6.02 0.7299 0.9481 0.6705 1.2387 0.9296 1.1279
PE 37:4; [M-H]-@6.72 1.0624 1.0514 0.8726 1.0449 0.9883 0.8745
PE 38:1; [M-H]-@7.53 0.9633 0.7620 1.2195 0.9490 0.8607 1.3196
PE 38:2; [M-H]-@6.95 1.1493 1.1159 0.9315 1.0720 0.6706 0.9307
PE 38:3; [M-H]-@7.31 0.9222 1.4404 0.9765 1.0887 1.0255 0.5932
PE 38:4; [M-H]-@7.02 1.1230 0.9849 0.9163 1.0985 0.7602 0.9119
PE 38:5; [M-H]-@6.57 0.9751 0.8953 0.9266 1.1439 0.7571 1.0590
PE 38:6; [M-H]-@6.20 0.7736 0.5820 1.3571 1.2189 0.8719 0.9598
PE 40:4; [M-H]-@7.50 1.0728 0.8970 0.8532 1.0930 0.8426 1.0098
PE 40:5; [M-H]-@7.25 0.9656 0.8366 0.9013 1.1071 1.0355 0.9353
PE 40:6; [M-H]-@6.97 0.9660 0.8917 0.8707 1.1723 0.7873 1.0143
PE 40:7; [M-H]-@6.47 0.8565 0.7967 1.2474 1.1322 0.8107 1.0428
PE 40:8; [M-H]-@6.04 0.9261 0.9564 0.9384 1.1063 0.7341 1.1866
PG 33:0; [M-H]-@6.10 1.0632 0.8507 1.5397 0.9685 0.6168 1.1121
PG 36:2; [M-H]-@6.08 1.0731 0.9201 0.8437 1.1102 0.8209 0.9820
PG 38:4; [M-H]-@6.07 0.8813 1.2635 0.8293 1.0104 1.1891 0.8832
PI 34:1; [M-H]-@5.71 0.9092 1.3112 0.6137 1.0798 1.2213 0.7635
PI 34:2; [M-H]-@5.26 1.1009 1.6470 0.6210 1.0127 0.8098 0.8474
PI 36:2; [M-H]-@5.92 1.1067 1.2968 0.8662 1.0312 0.7722 0.9042
PI 36:4; [M-H]-@5.26 1.3691 1.0533 0.6467 0.9823 0.7428 1.0063
PI 37:4; [M-H]-@5.59 1.0016 1.0155 1.0244 0.9868 0.9952 1.0068
PI 38:3; [M-H]-@6.10 1.3575 0.9212 0.8050 0.9798 0.7257 1.0272
PI 38:4; [M-H]-@5.88 1.3799 0.9023 0.6680 1.0690 0.6144 1.0045
PI 38:5; [M-H]-@5.40 0.9101 0.7927 0.7680 1.0938 0.9795 1.2142
PI 38:6; [M-H]-@5.14 0.8597 1.3156 0.8164 0.9600 0.9413 1.2510
PI 40:5; [M-H]-@5.99 1.2010 1.0545 0.7845 1.0356 0.7750 0.9813
PI 40:6; [M-H]-@5.83 0.9863 0.9268 0.7303 0.9841 0.9933 1.2908
plasmenyl-PE 32:1; [M-H]-@6.67 0.7811 0.8940 1.2341 1.1541 0.9596 0.8873
plasmenyl-PE 34:1; [M-H]-@7.27 0.9156 1.0740 0.9205 1.0866 0.7544 1.1596
plasmenyl-PE 34:2; [M-H]-@6.78 0.9252 1.1461 0.9237 1.1034 0.7343 1.0775
plasmenyl-PE 34:3; [M-H]-@6.42 0.6797 0.6316 1.6762 1.2160 0.6792 1.0388
plasmenyl-PE 36:1; [M-H]-@7.82 1.0214 1.0045 0.8380 1.0914 0.6771 1.1861
plasmenyl-PE 36:2; [M-H]-@7.36 0.9600 1.0774 0.8881 1.1248 0.7135 1.0714
plasmenyl-PE 36:3; [M-H]-@7.00 0.9546 1.1898 0.8492 1.1430 0.6749 1.0258
plasmenyl-PE 36:4; [M-H]-@6.73 1.0574 1.1402 0.7025 1.0758 0.5966 1.2548
plasmenyl-PE 36:5; [M-H]-@6.36 0.5845 0.6822 0.7575 1.3144 0.7225 1.4714
plasmenyl-PE 38:2; [M-H]-@7.97 1.0727 1.1452 0.8653 1.0577 0.9011 0.8603
plasmenyl-PE 38:3; [M-H]-@7.62 0.9614 0.8855 0.9947 1.0748 0.8010 1.1558
plasmenyl-PE 38:4; [M-H]-@7.31 1.0345 1.0982 0.8294 1.0449 0.6570 1.2405
plasmenyl-PE 38:5; [M-H]-@6.83 0.9904 1.1375 0.8079 1.0980 0.6649 1.1556
plasmenyl-PE 38:6; [M-H]-@6.62 1.0175 0.9277 0.8304 1.0677 0.7681 1.2117
plasmenyl-PE 40:3; [M-H]-@8.13 1.1268 0.9242 0.8459 1.0775 0.6985 1.1047
plasmenyl-PE 40:5; [M-H]-@7.35 1.0035 0.9076 0.7370 1.1368 0.7853 1.1279
plasmenyl-PE 40:6; [M-H]-@7.27 1.0521 0.9894 0.8439 1.0761 0.7758 1.0883
plasmenyl-PE 42:5; [M-H]-@7.95 0.9387 0.9125 0.6220 1.0870 0.8021 1.3870
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1visit:closeout
F2visit:initial visit
F3visit:intitial visit
F4visit:month 1
F5visit:month 12
F6visit:visit 1
  logo